Lopez, Romain https://orcid.org/0000-0003-0495-738X
Li, Baoguo
Keren-Shaul, Hadas
Boyeau, Pierre
Kedmi, Merav
Pilzer, David
Jelinski, Adam
Yofe, Ido
David, Eyal
Wagner, Allon
Ergen, Can
Addadi, Yoseph https://orcid.org/0000-0001-9827-0436
Golani, Ofra https://orcid.org/0000-0002-9793-236X
Ronchese, Franca https://orcid.org/0000-0001-5835-8230
Jordan, Michael I. https://orcid.org/0000-0001-8935-817X
Amit, Ido https://orcid.org/0000-0003-2968-877X
Yosef, Nir https://orcid.org/0000-0001-9004-1225
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI090023)
Chan-Zuckerberg BioHub
Article History
Received: 10 May 2021
Accepted: 7 March 2022
First Online: 21 April 2022
Competing interests
: N.Y. is an advisor and/or has equity in Cellarity, Celsius Therapeutics and Rheos Medicine. The other authors declare no competing interests.